Guardant Health
GH
#2543
Rank
A$8.89 B
Marketcap
$71.99
Share price
23.10%
Change (1 day)
104.49%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2024 (TTM): -A$0.77 Billion

According to Guardant Health 's latest financial reports the company's current earnings are A$0.69 Billion. In 2023 the company made an earning of -A$0.77 Billion, an increase over its 2022 earnings that were of -A$1.05 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.77 Billion-0.49%
2023 -A$0.77 Billion-26.73%
2022 -A$1.05 Billion69.96%
2021 -A$0.62 Billion56.35%
2020 -A$0.4 Billion252.69%
2019 -A$0.12 Billion-17.22%
2018 -A$0.14 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.34 Billion-58.54%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$50.38 Million-93.84%๐Ÿ‡บ๐Ÿ‡ธ USA